期刊文献+

益气清肺汤联合标准桃金娘油治疗AECOPD的临床疗效研究 被引量:6

Clinical study of decoction of invigorating Qi and clearing lung combined standardized myrtol on acute exacerbation of chronic obstructive pulmonary disease(AECOPD)
原文传递
导出
摘要 目的:探讨益气清肺汤联合标准桃金娘油治疗慢性阻塞性肺疾病急性加重期(AECOPD)的临床疗效。方法:将98例AECOPD患者随机分为治疗组50例和对照组48例。2组患者均给予常规治疗,对照组用标准桃金娘油每次300 mg,每天口服3次。治疗组用中药益气清肺汤,1剂/d,分2次口服,联合标准桃金娘油,2周后分别测定2组患者临床症状、血气分析及肺功能等指标。结果:2组治疗后FEV1,FEV1%均升高。而治疗组较对照组明显升高(P<0.01);治疗后2组均出现PaO2,PaO2/FiO2上升,PaCO2降低(P<0.01),但是治疗组与对照组比PaO2,PaO2/FiO2明显升高,PaCO2明显降低(P<0.01);临床控制率分别是治疗组42.0%,对照组20.83%,2组比较有显著性差异(P<0.05);显效率分别是治疗组86.0%,对照组52.08%,2组比较差异有统计学意义(P<0.01)。结论:益气清肺汤联合标准桃金娘油可明显改善AECOPD患者血气、肺功能及临床症状。 Objective: To investigate the clinical effect of decoction of invigorating Qi and clearing lung combined standardized myrtol on acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Method: Ninety and eight patients with AECOPD patients were randomly divided into the treatment group and the control group, with 50 cases and 48 cases respectively. All the patients were given the conventional treatment. The control group was treated by standardized myrtol with 3 times a day, 300 mg each time taken orally. The treatment group was given decoction of invigorating Qi and clearing lung with 2 times a day, one dose per day taken orally, combined standardized myrtol (usage as above). After Two weeks, the scores of clinical symptom, blood gas analysis and pul- monary function were observed. Result: Both FEV1 and FEV1% were raised in the two groups after treating. And the treatment group was significantly higher than control group ( P 〈 0.01 ). PaO2 and PaO2/FiO2 rose, with PaCO2 decreased in the two groups (P 〈 0. 01 ). PaO2 and PaO2/FiO2 were significantly improved, and PaCO2 was significantly decreased in the treatment group compared to the control group (P 〈 0. 01 ). In the clinical curative effect comparison aspects, clinical control rates were 42. 0% in treatment group and 20. 83% in control group respectively, with significant difference between the two groups (P 〈 0. 05). Significant efficiency is 86.0% in treatment group and 52.08% in control group respectively, with significant difference between the two groups (P 〈 O. O1 ). Conclusion: Decoction of invigorating Qi and clearing lung combined with standardized myrtol can obviously improve clinical symptom, blood gas an analysis and pulmonary function in patients with AECOPD.
出处 《中国中药杂志》 CAS CSCD 北大核心 2013年第3期440-442,共3页 China Journal of Chinese Materia Medica
关键词 慢性阻塞性肺疾病急性加重期(AECOPD) 益气清肺汤 标准桃金娘油 气道炎症 acute exacerbation of chronic obstructive pulmonary disease decoction of invigorating Qi and clearing lung standardized myrtol air way inflammation
  • 相关文献

参考文献4

二级参考文献18

  • 1有创-无创序贯机械通气多中心研究协作组.以肺部感染控制窗为切换点行有创与无创序贯机械通气治疗慢性阻塞性肺疾病所致严重呼吸衰竭的随机对照研究[J].中华结核和呼吸杂志,2006,29(1):14-18. 被引量:279
  • 2慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8230
  • 3Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends [J] . Lancet, 2007, 370 (9589) : 765-773.
  • 4Wedzicha JA, Seemungal TA. COPD exacerbations: defining their causeand prevention [J] . Lancet, 2007, 370 (9589) : 786-796.
  • 5Juergens UR, Stober M, Vetter H. and arach idonic acid metabolism human blood monocytes in vitro [J] 508-510. Inhibition of cytokine production by eucalyptol (1.8-cineole) in . Eur JMed Res, 1998, 3 (11) :.
  • 6Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases [J] . N Engl J Med, 1997, 336 (15) : 1066-1071.
  • 7GOLD Executive Committee[DB/OL].Guidelines:Global Strategy for Diagnosis,Management,and Prevention of COPD,November 2006[2006-11-18].http://www.goldcopd.com/Guidelineitem.asp? l1 =2-12 = 1&intId =989.
  • 8Celli BR,MacNee W,Committee members.Standard for the diagnosis and treatment of patients with COPD:a summary of the ATS/ERS position paper.Eur Respir J,2004,23:932-946.
  • 9Celli BR,Cote CG,Marin JM,ct al.The body mass index,airflow obstruction,dyspnea and exercise capacity index in chronic obstructive pulmonary disease.N Engl J Med,2004,350:1005-1012.
  • 10冉丕鑫 王辰 姚婉贞 等.我国部分地区慢性阻塞性肺疾病流行病学研究[J].中华结核和呼吸杂志,2007,.

共引文献8235

同被引文献63

  • 1王朴.生地黄的现代药理研究与临床应用[J].中国中医药现代远程教育,2008(8):986-986. 被引量:216
  • 2慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8230
  • 3楼启正.气红联用法研究标准桃金娘油的化学成分[J].光谱学与光谱分析,2007,27(5):924-927. 被引量:8
  • 4周仲瑛.中医内科学[M].北京:中国中医药出版社,2010:113.
  • 5中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南(2011年版)[J].中国医学前沿杂志,2012,4(1):69.
  • 6Nussbaumer-Ochsner Y & Rabe K F. Systemic manifestations of COPD [ J ]. Chest, 2011, 139 (1) :165.
  • 7GOLD Executive Committee Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease ( Updated 2009:48 ).
  • 8Jone P W, Quirk F H. Baveystock C M, et al. The St George' s Respiratory Questionnaire [ J ]. Respir Med, 1991,86(3) :25.
  • 9Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive sum- mary[J]. Am J Respir Crit Care Meal,2007,176(6):532-555.
  • 10Tse H, Raiteri L, Y Wong K,et al. High-dose N-acetylcys- teine in stable COPD[J]. Chest, 2013,12 : 2357.

引证文献6

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部